Why wouldn’t a European pharma company take advantage of the abuse and corruption in the American system? It boils down to this: drugs are a pretty anti-compet

Why wouldn’t a European pharma company take advantage of the abuse and corruption in the American system? It boils down to this: drugs are a pretty anti-competitive market, and the US doesn’t have much in the way of opposing rules that would bring prices down. No surprise that companies make more money compared to European countries. The real question is: if the US stopped allowing this and brought prices under control, would it wreck pharma R&D? People seem to assume the answer is “yes” when they bring up this disparity but I don’t see it being that obvious.